Drug Trial Radar · NCT06378866
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
532
Planned (sponsor's estimate)
Start
Jun 3, 2024
Primary completion
Feb 28, 2031
Study completion Feb 28, 2031
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Apr 23, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT) in treating patients with hormone sensitive prostate cancer that has spread from where it first started to other places in the body (metastatic), and that has come back after a period of improvement (recurrent). It also studies the effects of salvage radiation therapy (sXRT) on prostate cancer and to see if radiation to the pelvis helps prevent prostate cancer from spreading elsewhere. SBRT is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses given over several days. This type of radiation therapy helps spare normal tissue. Androgen can cause the growth of prostate cells. ADT lowers the amount of androgen made by the body. This may help stop the growth of tumor cells that need androgen to grow. Androgen receptor pathway inhibitors work by blocking the effects of androgen to stop the growth and spread of tumor cells. sXRT is a targeted radiation treatment for the prostate, typically given when cancer possibly returns after surgery or radiation. Its goal is to destroy any tumor cells in the area. Giving SBRT alone with watchful waiting may be as effective in treating prostate cancer as giving SBRT together with ARPI and ADT and sXRT may be effective in treating prostate cancer and preventing it from spreading elsewhere.
Conditions
- Recurrent Castration-Sensitive Prostate Carcinoma
- Recurrent Prostate Cancer
- Castration-resistant Prostate Cancer
- Biochemically Recurrent Prostate Carcinoma
Interventions
AbirateroneDrug
Given abiraterone
ApalutamideDrug
Given apalutamide
Biospecimen CollectionProcedure
Undergo blood sample collection
Bone ScanProcedure
Undergo bone scan
Computed TomographyProcedure
Undergo CT
DarolutamideDrug
Given darolutamide
DegarelixDrug
Given degarelix
EnzalutamideDrug
Given enzalutamide
GoserelinDrug
Given goserelin
HistrelinDrug
Given histrelin
LeuprolideDrug
Given leuprolide
Magnetic Resonance ImagingProcedure
Undergo MRI
Patient ObservationOther
Undergo watchful waiting or initial observation
Positron Emission TomographyProcedure
Undergo PET
PrednisoneDrug
Given prednisone
Questionnaire AdministrationOther
Ancillary studies
RelugolixDrug
Given relugolix
Stereotactic Body Radiation TherapyRadiation
Undergo SBRT
TriptorelinDrug
Given triptorelin
Radiation TherapyRadiation
Undergo sXRT
Image-Guided TherapyProcedure
Undergo image-guided therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Modified radiographic progression-free survival (mrPFS) (Groups A & B)Time frame: Up to 5 years
- Distant progression-free survival (PFS) (Groups C & D)Time frame: Up to 5 years
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic in Arizona
Phoenix, Arizona · Recruiting
Mayo Clinic in Florida
Jacksonville, Florida · Recruiting
Mayo Clinic in Rochester
Rochester, Minnesota · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.